Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byeongmin Park

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nanoscale|January 12, 2026
Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinantsDongwon Shin, Jiwoong Choi, Byeongmin Park, et al.
ACS Nano|February 28, 2025
Exosome-Inspired Lipid Nanoparticles for Enhanced Tissue PenetrationSeunghwan Bang, Byeongmin Park, Jae Chul Park, et al.
Pharmaceutics|February 25, 2023
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD PeptideGye Lim Kim, Byeongmin Park, Eun Hyang Jang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 20, 2024
Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer ImmunotherapyJiwoong Choi, Byeongmin Park, Jung Yeon Park, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 22, 2025
Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast CancerYoungri Ryu, Eun Hye Kim, Hochung Jang, et al.
Theranostics|January 8, 2025
Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failureByeongmin Park, Eun Hye Kim, Hochung Jang, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapyYeongji Jang, Jiwoong Choi, Byeongmin Park, et al.
Signal Transduction and Targeted Therapy|September 25, 2025
Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapyByeongmin Park, Jiwoong Choi, Jae-Hyeon Lee, et al.
ACS Nano|June 13, 2024
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel DiseaseByeongmin Park, Geonhee Han, Do Young Jin, et al.
ACS Nano|November 17, 2025
Oral PTP1B siRNA Delivery Using Milk-Derived Extracellular Vesicles for Alleviation of Acute Kidney InjuryHochung Jang, Daeho Park, Byeongmin Park, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nanoscale|January 12, 2026
Factors governing tumor penetration of nanomedicines: intrinsic and extrinsic determinantsDongwon Shin, Jiwoong Choi, Byeongmin Park, et al.
ACS Nano|February 28, 2025
Exosome-Inspired Lipid Nanoparticles for Enhanced Tissue PenetrationSeunghwan Bang, Byeongmin Park, Jae Chul Park, et al.
Pharmaceutics|February 25, 2023
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD PeptideGye Lim Kim, Byeongmin Park, Eun Hyang Jang, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 20, 2024
Light-Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer ImmunotherapyJiwoong Choi, Byeongmin Park, Jung Yeon Park, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 22, 2025
Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast CancerYoungri Ryu, Eun Hye Kim, Hochung Jang, et al.
Theranostics|January 8, 2025
Drug repositioning of mesalamine via supramolecular nanoassembly for the treatment of drug-induced acute liver failureByeongmin Park, Eun Hye Kim, Hochung Jang, et al.
Acta Pharmaceutica Sinica. B|October 6, 2025
Activatable PROTAC nanoassembly for photodynamic PTP1B proteolysis enhances glioblastoma immunotherapyYeongji Jang, Jiwoong Choi, Byeongmin Park, et al.
Signal Transduction and Targeted Therapy|September 25, 2025
Reprogramming of cancer metabolism via photoresponsive nano-PROTAC enhances pyroptosis-mediated immunotherapyByeongmin Park, Jiwoong Choi, Jae-Hyeon Lee, et al.
ACS Nano|June 13, 2024
Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel DiseaseByeongmin Park, Geonhee Han, Do Young Jin, et al.
ACS Nano|November 17, 2025
Oral PTP1B siRNA Delivery Using Milk-Derived Extracellular Vesicles for Alleviation of Acute Kidney InjuryHochung Jang, Daeho Park, Byeongmin Park, et al.
Pageof 2